# The TB-500 meds question, sorted by effects and safety evidence > TB-500 Meds? An Effects and Safety Evidence Panel — The meds panel sorts TB-500 recovery reports, adverse experiences, biological safety signals, and the unresolved fragment evidence. **effects file / rev3** Community reports stay anecdotal. Biological cautions stay cited. Missing human and combination evidence stays visible. ## Start here TB-500 is talked about as a recovery compound, yet the reports people share and the findings researchers publish are not the same kind of evidence. Community accounts describe less pain or stiffness, easier movement, injury recovery, skin healing, and occasional hair changes. They also include fatigue, injection-site reactions, headache, nausea, and mood changes. A report can identify a recurring theme, but it cannot prove the fragment caused it. The laboratory record is also easy to overread because most repair studies used full-length thymosin beta-4 rather than the short TB-500 fragment. Controlled human safety data for the fragment are absent. This card separates the layers: benefits and adverse experiences reported by communities, followed by the signed corpus's cited safety cautions. Where a concern comes only from biology and not a human outcome study, it is marked as theoretical. ## What people report These are effects reported by research-use communities — **anecdotal, not clinical evidence**. Frequency labels describe how often a theme appeared in the corpus sources; they are not measured rates and do not prove that the peptide caused the experience. **Reported benefits** - **Faster recovery from tendon, ligament and muscle injuries — very commonly reported.** The dominant community theme is a faster return from soft-tissue injury, with wide variation and no controlled human confirmation. - **Less joint pain and stiffness, better range of motion — frequently reported.** People often pair less aching with easier movement; the reports do not establish cause. - **Improved overall flexibility and mobility — frequently reported.** Everyday movement and training can feel easier in some accounts, but the effect has not been measured under study conditions. - **Feeling of reduced inflammation or 'calmed down' soreness — occasionally reported.** Some accounts describe less swelling or post-exercise soreness; no human fragment trial confirms an anti-inflammatory effect. - **Better wound and skin healing — occasionally reported.** Cuts, surgical sites, and irritated skin appear in occasional stories, while the aligned wound literature is mainly animal work on the parent protein. - **Hair regrowth or thicker hair — rarely reported.** Hair change is a minor, inconsistent signal often mixed with other interventions. **Reported adverse effects** - **Injection-site redness, swelling or aching — very commonly reported.** Local soreness, redness, or swelling is the most repeated adverse report. - **Temporary tiredness or lethargy — frequently reported.** Short-lived tiredness is one of the more consistent whole-body complaints. - **Head rush, lightheadedness or headache — occasionally reported.** Brief lightheadedness and headache appear less often than fatigue or local reactions. - **Brief flu-like feeling — occasionally reported.** A small group describes a short run-down or feverish feeling early in use. - **Nausea — rarely reported.** Nausea is an uncommon and usually mild community report. - **Heightened awareness of an existing injury — rarely reported.** Some people say an old injury feels more noticeable; this is a sensation, not proof of repair activity. - **Temporary low mood or mood changes — rarely reported.** Short-lived mood changes appear rarely, with no clinical evidence linking them to TB-500. ## Safety and cautions **Human safety in people is essentially unstudied.** No completed controlled human trial has tested the TB-500 heptapeptide, so its safety profile in people remains unknown. [10] [6] **Theoretical cancer / tumor-growth concern.** The tumor concern is theoretical but biologically specific: full-length thymosin beta-4 has links to cell migration, angiogenesis, and tumor progression in laboratory research. [19] [20] **Banned in competitive sport (WADA-prohibited).** TB-500 is prohibited in tested sport, and analytical methods can detect the peptide and its breakdown products. [21] [10] **Reported benefits may overstate what the peptide actually does.** A long-term mouse study increased regenerating muscle fibers without improving strength, heart function, or fibrosis; a repair marker did not become a functional gain. [22] **TB-500 is a fragment, not the full thymosin beta-4 protein.** TB-500 is the Ac-LKKTETQ fragment, not full-length thymosin beta-4. Applying whole-protein findings to the fragment is an unconfirmed extrapolation. [21] [5] **Research-grade product quality is not guaranteed.** Unregulated research material can vary in identity, sequence, and purity, making both reactions and claimed results harder to interpret. [23] **Theoretical bleeding, surgery and clotting considerations.** **Theoretical caution.** Bleeding, surgery, and clotting concerns are theoretical. The corpus contains no direct human fragment study that measures those outcomes. **Theoretical caution in pregnancy, breastfeeding and the young.** **Theoretical caution.** Pregnancy, breastfeeding, and developmental cautions are also theoretical because cell movement and blood-vessel growth are basic developmental processes and no human safety data exist. --- The TB-500 record drawn as a comic page — each repair figure, stroke dose and safety signal inked into its own panel and logged to its study, the fragment-versus-full-length caveat stamped on every page, with no clinic behind the gutters and nothing here dispensed or sold.